Book contents
- Frontmatter
- Contents
- Preface
- Contributors
- Part I Clinical Syndromes – General
- Part II Clinical Syndromes – Head and Neck
- Part III Clinical Syndromes – Eye
- Part IV Clinical Syndromes – Skin and Lymph Nodes
- Part V Clinical Syndromes – Respiratory Tract
- Part VI Clinical Syndromes – Heart and Blood Vessels
- Part VII Clinical Syndromes – Gastrointestinal Tract, Liver, and Abdomen
- Part VIII Clinical Syndromes – Genitourinary Tract
- Part IX Clinical Syndromes – Musculoskeletal System
- Part X Clinical Syndromes – Neurologic System
- Part XI The Susceptible Host
- Part XII HIV
- Part XIII Nosocomial Infection
- Part XIV Infections Related to Surgery and Trauma
- Part XV Prevention of Infection
- Part XVI Travel and Recreation
- Part XVII Bioterrorism
- Part XVIII Specific Organisms – Bacteria
- 121 Actinomycosis
- 122 Anaerobic Infections
- 123 Anthrax and Other Bacillus Species
- 124 Bartonellosis (Carrión's Disease)
- 125 Cat Scratch Disease and Other Bartonella Infections
- 126 Bordetella
- 127 Moraxella (Branhamella) Catarrhalis
- 128 Brucellosis
- 129 Campylobacter
- 130 Clostridia
- 131 Corynebacteria
- 132 Enterobacteriaceae
- 133 Enterococcus
- 134 Erysipelothrix
- 135 HACEK
- 136 Helicobacter Pylori
- 137 Gonococcus: Neisseria Gonorrhoeae
- 138 Haemophilus
- 139 Legionellosis
- 140 Leprosy
- 141 Meningococcus and Miscellaneous Neisseriae
- 142 Listeria
- 143 Nocardia
- 144 Pasteurella Multocida
- 145 Pneumococcus
- 146 Pseudomonas, Stenotrophomonas, and Burkholderia
- 147 Rat-Bite Fevers
- 148 Salmonella
- 149 Staphylococcus
- 150 Streptococcus Groups A, B, C, D, and G
- 151 Viridans Streptococci
- 152 Poststreptococcal Immunologic Complications
- 153 Shigella
- 154 Tularemia
- 155 Tuberculosis
- 156 Nontuberculous Mycobacteria
- 157 Vibrios
- 158 Yersinia
- 159 Miscellaneous Gram-Positive Organisms
- 160 Miscellaneous Gram-Negative Organisms
- Part XIX Specific Organisms – Spirochetes
- Part XX Specific Organisms – Mycoplasma and Chlamydia
- Part XXI Specific Organisms – Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific Organisms – Fungi
- Part XXIII Specific Organisms – Viruses
- Part XXIV Specific Organisms – Parasites
- Part XXV Antimicrobial Therapy – General Considerations
- Index
158 - Yersinia
from Part XVIII - Specific Organisms – Bacteria
Published online by Cambridge University Press: 05 March 2013
- Frontmatter
- Contents
- Preface
- Contributors
- Part I Clinical Syndromes – General
- Part II Clinical Syndromes – Head and Neck
- Part III Clinical Syndromes – Eye
- Part IV Clinical Syndromes – Skin and Lymph Nodes
- Part V Clinical Syndromes – Respiratory Tract
- Part VI Clinical Syndromes – Heart and Blood Vessels
- Part VII Clinical Syndromes – Gastrointestinal Tract, Liver, and Abdomen
- Part VIII Clinical Syndromes – Genitourinary Tract
- Part IX Clinical Syndromes – Musculoskeletal System
- Part X Clinical Syndromes – Neurologic System
- Part XI The Susceptible Host
- Part XII HIV
- Part XIII Nosocomial Infection
- Part XIV Infections Related to Surgery and Trauma
- Part XV Prevention of Infection
- Part XVI Travel and Recreation
- Part XVII Bioterrorism
- Part XVIII Specific Organisms – Bacteria
- 121 Actinomycosis
- 122 Anaerobic Infections
- 123 Anthrax and Other Bacillus Species
- 124 Bartonellosis (Carrión's Disease)
- 125 Cat Scratch Disease and Other Bartonella Infections
- 126 Bordetella
- 127 Moraxella (Branhamella) Catarrhalis
- 128 Brucellosis
- 129 Campylobacter
- 130 Clostridia
- 131 Corynebacteria
- 132 Enterobacteriaceae
- 133 Enterococcus
- 134 Erysipelothrix
- 135 HACEK
- 136 Helicobacter Pylori
- 137 Gonococcus: Neisseria Gonorrhoeae
- 138 Haemophilus
- 139 Legionellosis
- 140 Leprosy
- 141 Meningococcus and Miscellaneous Neisseriae
- 142 Listeria
- 143 Nocardia
- 144 Pasteurella Multocida
- 145 Pneumococcus
- 146 Pseudomonas, Stenotrophomonas, and Burkholderia
- 147 Rat-Bite Fevers
- 148 Salmonella
- 149 Staphylococcus
- 150 Streptococcus Groups A, B, C, D, and G
- 151 Viridans Streptococci
- 152 Poststreptococcal Immunologic Complications
- 153 Shigella
- 154 Tularemia
- 155 Tuberculosis
- 156 Nontuberculous Mycobacteria
- 157 Vibrios
- 158 Yersinia
- 159 Miscellaneous Gram-Positive Organisms
- 160 Miscellaneous Gram-Negative Organisms
- Part XIX Specific Organisms – Spirochetes
- Part XX Specific Organisms – Mycoplasma and Chlamydia
- Part XXI Specific Organisms – Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific Organisms – Fungi
- Part XXIII Specific Organisms – Viruses
- Part XXIV Specific Organisms – Parasites
- Part XXV Antimicrobial Therapy – General Considerations
- Index
Summary
INTRODUCTION
Yersinia genus includes several species. The most important for human disease are Yersinia enterocolitica, Yersinia pseudotuberculosis, and Y. pseudotuberculosis subspecies pestis. More commonly Y. pseudotuberculosis subspecies pestis is listed as Yersinia pestis. Yersinia pseudotuberculosis and Y. pestis are clearly closely related species by analysis of the genome. However, Y. enterocolitica and Y. pseudotuberculosis produce clinically similar disease and both are quite distinct from that produced by subspecies Y. pestis; hence, in this chapter the older terminology Y. pestis will be used, and Y. enterocolitica and Y. pseudotuberculosis discussed separately.
YERSINIA PESTIS
The well-known unfortunate events of September 11, 2001, have produced a resurgence in interest in an ancient organism. Additionally, Y. pestis has been classified as a re-emerging pathogen. Yersinia pestis was first identified by Alexander Yersin in 1894 during an outbreak in Hong Kong. Yersinia pestis is typically a zoonosis with human infection an incidental event. Domestic dogs and cats can also transmit the disease to humans. The disease is variably distributed throughout the world. Its distribution in the United States is largely limited to the west, particularly New Mexico, Arizona, and California.
- Type
- Chapter
- Information
- Clinical Infectious Disease , pp. 1099 - 1102Publisher: Cambridge University PressPrint publication year: 2008